Patents by Inventor Charlene Levering
Charlene Levering has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200040352Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: ApplicationFiled: August 14, 2019Publication date: February 6, 2020Inventors: Charlene Levering, David Whalen, Stephen Temple, Mark McCaslin, Marry S. Reddy, William Hiatt, Wen C. Bums, Richard Eric Cerny
-
Patent number: 10385355Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: GrantFiled: June 2, 2017Date of Patent: August 20, 2019Assignees: Monsanto Technology LLC, Forage Genetics International, LLCInventors: Charlene Levering, David Whalen, Stephen Temple, Mark McCaslin, Marry S. Reddy, William Hiatt, Wen C. Burns, Richard Eric Cerny
-
Publication number: 20170327835Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: ApplicationFiled: June 2, 2017Publication date: November 16, 2017Inventors: Charlene Levering, David Whalen, Stephen Temple, Mark McCaslin, Marry S. Reddy, William Hiatt, Wen C. Burns, Richard Eric Cerny
-
Patent number: 9701976Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: GrantFiled: June 28, 2012Date of Patent: July 11, 2017Assignees: Monsanto Technology LLC, Forage Genetics International LLCInventors: Charlene Levering, David Whalen, Stephen Temple, Mark McCaslin, Marry S. Reddy, William Hiatt, Wen C. Burns, Richard Eric Cerny
-
Patent number: 9670498Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: GrantFiled: November 18, 2016Date of Patent: June 6, 2017Assignee: Ceres, Inc.Inventors: Charlene Levering, David Whalen, Stephen Temple, Mark McCaslin, Marry S. Reddy, William Hiatt, Wen C. Burns, Richard Eric Cerny
-
Publication number: 20170067068Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: ApplicationFiled: November 18, 2016Publication date: March 9, 2017Inventors: Charlene Levering, David Whalen, Stephen Temple, Mark McCaslin, Marry S. Reddy, William Hiatt, Wen C. Burns, Richard Eric Cerny
-
Publication number: 20140259227Abstract: The present invention provides a transgenic alfalfa event KK 179-2. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a alfalfa plant. The invention further provides methods for detecting the presence of said alfalfa event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said alfalfa event.Type: ApplicationFiled: June 28, 2012Publication date: September 11, 2014Inventors: Charlene Levering, Richard Eric Cerny
-
Patent number: 7605244Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: GrantFiled: July 11, 2007Date of Patent: October 20, 2009Assignee: Monsanto Technology LLCInventors: Alison Van Eenennaam, Henry E. Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Patent number: 7595382Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: GrantFiled: July 11, 2007Date of Patent: September 29, 2009Assignee: Monsanto Technology LLCInventors: Alison Van Eenennaam, Henry E. Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Patent number: 7553952Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: GrantFiled: July 11, 2007Date of Patent: June 30, 2009Assignee: Monsanto Technology LLCInventors: Alison Van Eenennaam, Henry E. Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Publication number: 20080020444Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: ApplicationFiled: July 11, 2007Publication date: January 24, 2008Inventors: Alison Eenennaam, Henry Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Publication number: 20080016592Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: ApplicationFiled: July 11, 2007Publication date: January 17, 2008Inventors: Alison Eenennaam, Henry Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Publication number: 20080016591Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: ApplicationFiled: July 11, 2007Publication date: January 17, 2008Inventors: Alison Eenennaam, Henry Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Patent number: 7244877Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: GrantFiled: August 16, 2002Date of Patent: July 17, 2007Assignee: Monsanto Technology LLCInventors: Alison Van Eenennaam, Henry E. Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering
-
Publication number: 20030166205Abstract: The present invention relates to the isolation of nucleic acid sequences upstream of the gamma-tocopherol methyltransferase (GMT) coding sequence in the genome of Brassica napus and the use of such sequences in methods to control gene expression of polypeptides, preferably GMT in plants. The present invention further pertains to methods of regulating expression of polypeptides using transcription factors, preferably zinc finger transcription factors and the isolated nucleic acid sequences upstream of the gene encoding GMT which contain binding sites for the transcription factors.Type: ApplicationFiled: February 7, 2002Publication date: September 4, 2003Inventors: Alison Van Eenennaam, Eric Aasen, Charlene Levering
-
Publication number: 20030154513Abstract: The present invention relates to genes associated with the tocopherol biosynthesis pathway. More particularly, the present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with genes that encode polypeptides that have methyltransferase activity. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express the aforementioned polypeptides. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.Type: ApplicationFiled: August 16, 2002Publication date: August 14, 2003Inventors: Alison Van Eenennaam, Henry E. Valentin, Balasulojini Karunanandaa, Ming Hao, Eric Aasen, Charlene Levering